Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-058365

CBO & EVP acquired 109,734 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kassberg Thomas Richard · CBO & EVP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-09-30 Exercise or conversion : show line 1 in the form +109,734 $0.31 $34,018 216,552 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-30 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −109,734 0 D
Loading xslF345X03/doc4.xml…